C

녹십자웰빙

234690KOSDAQ의약품 제조업

53.4 / 100

Reference Date: 2026-06-10

Financial Score21.0 / 40
News Sentiment20.4 / 25
Momentum2.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE significantly exceeds the industry average but the high debt ratio poses financial risk. Plunged 34.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

LS Wellbeing operates in professional pharmaceuticals, clinic-based health functional foods, and medical devices/cosmetics (aesthetics), achieving a 6.1% revenue growth to 127.9 billion KRW in 2024. Key products include injectable nutritional solutions like Lainex Injection, health functional food brand Dr.PNT, and medical devices such as HA fillers and skin boosters, with active exports to the Chinese market.

Number of Employees

330people

Average Salary

71.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
14.20Industry Average 11.933.0Point

Higher than industry avg (caution)

PBR
1.28Industry Average 0.892.5Point

Higher than industry avg (caution)

ROE
9.20Industry Average 4.017.0Point

2.3x industry avg (excellent)

Debt Ratio
30.62Industry Average 12.430.0Point

2.5x industry avg (risky)

Trend 2023~20258.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲17.0% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲28.7% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 7.7% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 81.7

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 8,010Won52-week high 15,10052-week low 8,010
1-month return0.0Point

1m -34.77% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral분기보고서 (2026.03)2026-05-15
  • Neutral파생상품거래손실발생2026-05-15